Lifemd Inc (LFMD) Stock Price, Quote & News

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services

Sector: Healthcare

Phone: 866 351 5907

Website: lifemd.com

Address:

236 Fifth Avenue, Suite 400, New York, United States

LupusLeoqueGlobalPartnrs Aug. 23 at 10:18 PM

LIl bro is big mad 🤣 $LFMD $HIMS

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 7:49 PM

@Yourearegard $HIMS $LFMD "aIn'T rEaDiN AlLaT" We want to apologize. Our intention was never to cause harm or show disrespect toward individuals with intellectual or developmental disabilities.

2 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 6:39 PM

@Yourearegard Yea... literacy does not seem to be your strong suit. We'll sum it up for you.. (tomorrow) we're "hoping your supervisor grants you the luxury of a half day" 🤣 $LFMD $HIMS

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 6:16 PM

@Yourearegard LMAO Homie is really trying to shill $HIMS and $HOOD For the record, these are all the hedge funds we beat over a 3-year period. “Almost 100% gain” is better than a “theoretical 1,000x iF yOu BoUgHt…” Post some numbers, homie. We don’t deal theoretics; we deal in numbers. Tomorrow, we’ll be opening a sizable position in $LFMD and nudging that extra 0.001% on our way to a full 100% gain, while you’ll be clocking twelve hours at a local machine shop, hoping your supervisor grants you the luxury of a half day.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 4:26 PM

$LFMD Excited for monday! Citadel added the stock, Vanguard and BlackRock increased their positions 🚀🚀

0 · Reply

thejman1 Aug. 23 at 6:26 AM

$LFMD chuck royce sold their position for a loss. so this has nothing holding it at all anymore. no institutions are in on lfmd it looks like.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 1:41 AM

$HIMS Sure you have, homie. I'm sure you've mad so much money, you don't want to post numbers. $HOOD is a sub $5 stock, what is your point? Just because Vlad decided to add gambling to his platform does not make it “good” all of a sudden. We are much more confident in our $LFMD order, Monday.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 12:47 AM

@Yourearegard Oh man. We understand why you’re so upset, lil’ bro...🤣🤣 The real embarrassment is double digit losses 💯 $HIMS $SMCI $LFMD

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 11:29 PM

1,000 shares of $LFMD was not enough.

0 · Reply

ClarissaLove Aug. 22 at 10:50 PM

$LFMD $HIMS I pulled my numbers from the SEC filings and you’re using ChatGPT for your DD. You do realize quarterly reports are filed with the SEC? You’re a fucking idiot. LFMD lost 9000 subscribers from Q1 to Q2 and revenue declined by $3M from Q1 to Q2. Dispute that.

0 · Reply

LifeMD price target lowered to $5 from $8 at KeyBanc

2026-08-07T10:26:36.000Z - 17 days ago

LifeMD price target lowered to $9 from $10 at H.C. Wainwright

2026-08-06T13:45:43.000Z - 18 days ago

LifeMD price target lowered to $8 from $10 at B. Riley

2026-08-06T13:16:23.000Z - 18 days ago

LifeMD price target lowered to $5 from $8 at Lake Street

2026-08-06T11:23:24.000Z - 18 days ago

LifeMD price target lowered to $7 from $8 at Mizuho

2026-08-06T10:01:04.000Z - 18 days ago

LifeMD price target lowered to $9 from $10 at BTIG

Aug 5, 2026, 7:45 PM EDT - 18 days ago

UPDATE - LifeMD Reports Second Quarter 2026 Results

LFMDP

2026-08-05T22:05:37.000Z - 18 days ago

LifeMD sees Q3 revenue $48M-$51M, consensus $58.55M

2026-08-05T22:05:26.000Z - 18 days ago

LifeMD cuts FY26 revenue view to $205.5M-$212.5M from $220M-$230M

2026-08-05T22:00:38.000Z - 18 days ago

LifeMD reports Q2 EPS (16c), consensus (5c)

Aug 5, 2026, 4:30 PM EDT - 18 days ago

LifeMD Earnings Call Transcript: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

LifeMD Earnings release: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

LifeMD Slides: Q2 2026

Aug 5, 2026, 4:30 PM EDT - 18 days ago

LifeMD Quarterly report: Q2 2026

Jul 24, 2026, 4:05 PM EDT - 4 weeks ago

LifeMD to Report Second Quarter 2026 Financial Results on August 5

LFMDP

Jun 23, 2026, 8:00 AM EDT - 2 months ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

LFMDP

2026-06-22T13:43:30.000Z - 2 months ago

LifeMD partners with Halozyme subsidiary for exclusive testosterone program

HALO

Jun 22, 2026, 8:00 AM EDT - 2 months ago

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

LFMDP

2026-06-01T14:34:47.000Z - 3 months ago

LifeMD appoints Umesh Sripad as chief technology officer

Jun 1, 2026, 8:05 AM EDT - 3 months ago

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LFMDP

May 19, 2026, 12:00 PM EDT - 3 months ago

LifeMD Transcript: 16th Annual LD Micro Invitational Conference

May 15, 2026, 8:00 AM EDT - 3 months ago

LifeMD to Participate in Upcoming Investor Conferences

LFMDP

May 7, 2026, 7:00 AM EDT - 3 months ago

LifeMD Slides: Investor presentation

2026-05-07T00:47:06.000Z - 3 months ago

LifeMD reports Q1 EPS (20c), consensus (12c)

2026-05-07T00:46:21.000Z - 3 months ago

LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M

2026-05-07T00:45:57.000Z - 3 months ago

LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

LifeMD Quarterly report: Q1 2026

May 6, 2026, 4:05 PM EDT - 3 months ago

LifeMD Reports First Quarter 2026 Results

Apr 30, 2026, 8:00 AM EDT - 4 months ago

LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

LifeMD Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

LifeMD to Report First Quarter 2026 Financial Results on May 6

LFMDP

2026-04-24T17:05:27.000Z - 4 months ago

LifeMD management to meet with BTIG

2026-04-10T12:26:19.000Z - 4 months ago

LifeMD now offering Foundayo from Eli Lilly

LLY

Apr 10, 2026, 8:15 AM EDT - 4 months ago

LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LFMDP

2026-03-31T14:25:15.000Z - 5 months ago

LifeMD announces launch of Wegovy subscription program

NVO

Mar 31, 2026, 8:45 AM EDT - 5 months ago

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LFMDP

2026-03-17T15:41:34.000Z - 5 months ago

LifeMD management to meet virtually with B. Riley

Mar 16, 2026, 8:00 AM EDT - 5 months ago

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

2026-03-16T08:40:05.000Z - 5 months ago

LifeMD upgraded to Outperform from Neutral at Mizuho

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

LifeMD Slides: Q4 2025

Mar 9, 2026, 4:05 PM EDT - 5 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMDP

Mar 3, 2026, 4:05 PM EST - 6 months ago

LifeMD to Participate in Two Investor Conferences During March

LFMDP

Feb 23, 2026, 8:00 AM EST - 6 months ago

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

LFMDP

Jan 6, 2026, 8:30 AM EST - 8 months ago

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

LFMDP

Jan 5, 2026, 8:05 AM EST - 8 months ago

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

LFMDP

Nov 24, 2025, 8:00 AM EST - 9 months ago

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Earnings Call Transcript: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Quarterly report: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Earnings release: Q3 2025

Nov 17, 2025, 4:30 PM EST - 9 months ago

LifeMD Slides: Q3 2025

Nov 17, 2025, 4:05 PM EST - 9 months ago

LifeMD Reports Third Quarter 2025 Results

LFMDP

Nov 17, 2025, 8:00 AM EST - 10 months ago

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

LFMDP

Nov 10, 2025, 8:00 AM EST - 10 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMDP

Nov 5, 2025, 5:15 PM EST - 10 months ago

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

LFMDP

Nov 4, 2025, 9:15 AM EST - 10 months ago

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

LFMDP

Oct 23, 2025, 8:00 AM EDT - 10 months ago

LifeMD to Report Third Quarter 2025 Financial Results on November 6

Oct 22, 2025, 8:00 AM EDT - 10 months ago

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program

Sep 30, 2025, 8:14 AM EDT - 11 months ago

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

NVO

Sep 30, 2025, 8:00 AM EDT - 11 months ago

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

LupusLeoqueGlobalPartnrs Aug. 23 at 10:18 PM

LIl bro is big mad 🤣 $LFMD $HIMS

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 7:49 PM

@Yourearegard $HIMS $LFMD "aIn'T rEaDiN AlLaT" We want to apologize. Our intention was never to cause harm or show disrespect toward individuals with intellectual or developmental disabilities.

2 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 6:39 PM

@Yourearegard Yea... literacy does not seem to be your strong suit. We'll sum it up for you.. (tomorrow) we're "hoping your supervisor grants you the luxury of a half day" 🤣 $LFMD $HIMS

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 6:16 PM

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 4:26 PM

$LFMD Excited for monday! Citadel added the stock, Vanguard and BlackRock increased their positions 🚀🚀

0 · Reply

thejman1 Aug. 23 at 6:26 AM

$LFMD chuck royce sold their position for a loss. so this has nothing holding it at all anymore. no institutions are in on lfmd it looks like.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 1:41 AM

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 23 at 12:47 AM

@Yourearegard Oh man. We understand why you’re so upset, lil’ bro...🤣🤣 The real embarrassment is double digit losses 💯 $HIMS $SMCI $LFMD

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 11:29 PM

1,000 shares of $LFMD was not enough.

0 · Reply

ClarissaLove Aug. 22 at 10:50 PM

0 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 10:06 PM

We will 100% continue to us LLMs as part of our research and “due diligence”. We already admitted we misread the numbers with $LFMD , however 99% PLUS return over 3 years says that (historically) we know value when we see it. You don’t trust SEC filings but you DO trust quarterly reports. Make that make sense 😆🤣

0 · Reply

ClarissaLove Aug. 22 at 9:28 PM

$HIMS $LFMD I would trust SEC filings over AI chat bots my friend.

0 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 6:18 PM

$LFMD This also aged well @ClarissaLove 😆😆😆😆😆😆

0 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 6:12 PM

LMAO Homie clearly trying to shill $HIMS . This is the information available online my guy, your numbers all BS you pulled out of you’re a$$. Granted, we used ChatGPT for a synopsis however you’re just creaming about numbers with 0 citation. We also beat every single index over the past 3 years. Sucking is not in our vernacular. We know a play when we see one. Monday morning, regadless of what you shill... we will open a large $LFMD position.

1 · Reply

ClarissaLove Aug. 22 at 4:36 PM

$LFMD Revenue went from $50.2M in Q1 to 47.2 in Q2, a decline of $3M. Total subscribers declined from 365,000 in Q1 to 356,000 in Q2, a loss of 9000 total subscribers. It sucks to suck doesn’t it? You’re a fucking idiot.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 22 at 4:24 PM

$LFMD Aging like fine gym socks.

1 · Reply

LupusLeoqueGlobalPartnrs Aug. 21 at 9:16 PM

$LFMD Nearing 52-week lows, BlackRock and Vanguard are a large owner AND hit profitability in 2025?? Sign us up!

0 · Reply

ClarissaLove Aug. 20 at 12:09 PM

$LFMD Pretty sure @Alex1965 sold his position here. Not a peep from him about this stock since July 23. Not even one comment about the earnings report. He’s actively pumping his other stocks though!

1 · Reply

ClarissaLove Aug. 19 at 12:54 PM

$LFMD what happened to the guy that said this would never hit the 3s again, he’s been gone for nearly a month 😂😂🤭

1 · Reply

volki19 Aug. 19 at 4:59 AM

$LFMD Institutions increased their positions meaningfully from the latest 13Fs in August. Of course the data reflects the positions before the earnings. Nonetheless this looks positive and buyers outnumberd the sellers.

0 · Reply

rolypoly101 Aug. 17 at 2:42 PM

$LFMD LifeMD got screwed by Novo despite them playing by the book. The profit difference between compounded and branded is massive and LifeMD switched soon as they were supposed to, which not only lost them on pricing competitiveness, they also took over a year to recover. If LifeMD simply continued the same way HIMS did, they would be doing far better financially. It's not really management being incompetent, it's because management decided to play it straight, that they are struggling but as you can see, even HIMS is losing money now that they switched to branded. Q4 ER will be the biggest one for them and according to them, when they will finally turn this around.

3 · Reply

ClarissaLove Aug. 13 at 10:29 PM

$LFMD They should have sold the telehealth business and kept WorkSimpli.

1 · Reply

Market Cap	159.55M
Revenue (ttm)	194.06M
Net Income (ttm)	14.35M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	7.39%
Debt to Equity Ratio	0.00

Volume	213,481
Avg Vol	986,566
Day's Range	N/A - N/A
Shares Out	48.20M
Stochastic %K	22%
Beta	2.02
Analysts	Strong Sell
Price Target	$8.12